VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
At week 2, FMX114 demonstrated a statistically significant reduction in both absolute and percent change…
Sylogist Announces Second Quarter 2026 Results
Geomorphic AI Doubles Pora Gold Project in Finland to 20,601 Hectares with Surface Samples up to 12.8 g/t Au and Boulders up to 28 g/t Au
Almabase Launches Unified Fundraising Platform for Healthcare Foundations
A Brighter Future Is on the Way
Zakat Coin (ZKTC) Raises $5 Million in Just Four Days on Coinstore, Led by CTO Arslan Naseem